Essa Pharma Inc Reports Results For The Quarter Ended In June: Earnings Summary

ESSA Pharma

08/08/2023 13:57

* ESSA Pharma Inc  EPIX.OQ  reported a quarterly adjusted
loss
of 17 cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 19 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * ESSA Pharma Inc's reported EPS for the quarter was a loss
of 17
cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * ESSA Pharma Inc shares had risen by 6.3% this quarter and
gained 13.9% so far this year.
    * The company reported a quarterly loss of $7.26 million.
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $17.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 12:57 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.19          -0.17          Beat
 Mar. 31 2023      -0.20          -0.16          Beat
 Dec. 31 2022      -0.23          -0.15          Beat
 Sep. 30 2022      -0.27          -0.14          Beat